VRNA overbought on positive lung cancer results. These money losing pharma stocks always tend to overshoot. We should correct under $15 in coming days. Purchased 50 Feb 17th $20 puts. Will add for each $1 increase in share price.
Komen:
Added twice today 70 puts total will add 10 puts each $1 increase